tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily

Oramed Pharm (ORMP) Stock Investors

511 Followers
Based on 769,291 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ORMP
On average, investors allocate 6.95% of their portfolios to ORMP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,291 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ORMP

7.4%
Last 7
Days
2.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ORMP, out of 769,291 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ORMP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,697 investors who made their portfolios public
The table shows changes in ORMP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ORMP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.20%
-1.18%
-0.87%
1.75B
Industrials
DraftKings
5.47%
-1.55%
+0.62%
38.05B
Consumer Cyclical
XPeng, Inc. ADR
5.51%
-1.45%
-1.51%
12.63B
Consumer Cyclical
Viking Therapeutics
4.53%
+0.19%
+7.08%
5.74B
Healthcare
Lucid Group
5.79%
-1.34%
+1.51%
6.32B
Consumer Cyclical
Nio
9.70%
-0.77%
+0.43%
10.07B
Consumer Cyclical
Block
4.46%
+0.68%
+2.99%
56.87B
Technology
Carnival
6.44%
-0.18%
+7.66%
31.45B
Consumer Cyclical
Bristol-Myers Squibb
3.56%
-0.57%
-1.16%
118.10B
Healthcare
Marathon Digital Holdings
5.67%
+1.72%
+5.82%
6.39B
Financial
Based on the activity of 769,291 active portfolios
Open your Smart Portfolio

ORMP Investor Analysis

ORMP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.7%
of ORMP holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
ORMP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
46.3%
of ORMP holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
ORMP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.0%
of ORMP holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of ORMP stock investors
See who invests in ORMP according to age group and performance.

FAQ

How many retail Investors hold ORMP?
<0.1% of TipRanks' retail investors hold ORMP in their portfolios.
    What is ORMP Investor Sentiment?
    ORMP’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ORMP in the last 7 days?
      ▲ 7.4% of TipRanks' retail investors changed their holding of ORMP in the last 7 days.
        What percentage of retail investors changed their holding of ORMP in the last 30 days?
        ▲ 2.8% of TipRanks' retail investors changed their holding of ORMP in the last 30 days.
          What is the average age of retail investors who hold ORMP?
          The average age of ORMP Holders is between 35–55.
            What other stocks have ORMP investors also bought?
            ORMP Investors also bought PLUG, DKNG, XPEV, VKTX, LCID, NIO, SQ, CCL, BMY, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CRMDCormedix
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis